Article
Biological impediments to monoclonal antibody–based cancer immunotherapy
1 Nov 2004
Abstract excerpt
The ability of antibodies to exploit antigenic differences between normal and malignant tissues and to exact a variety of antitumor responses offers significant advantages to conventional forms of therapy. Several monoclonal antibodies (mAb) have already proved to be relatively well tolerated and effective for the treatment of many different malignant diseases. However, mAbs must overcome substantial obstacles to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.